AMLX vs CTSH · $561.6M cap vs P/E 12, rev $21.11B
Amylyx Pharmaceuticals Inc (AMLX) versus Cognizant Technology Solutions Corp Class A (CTSH) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
Latest reported CTSH revenue for 2025-12-31 was $21.11B. Net income was $2.23B. Revenue was up 7.0% from 2024-12-31 to 2025-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
AMLX currently screens at market cap $561.6M. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
Not investment advice. Open the AMLX and CTSH stock pages for the full models.
Not investment advice.